WIPO logo
모바일 | Deutsch | English | Español | Français | 日本語 | Português | Русский | 中文 | العربية |
PATENTSCOPE

국제 및 국내 특허문헌 검색
World Intellectual Property Organization
검색
 
열람
 
번역
 
옵션
 
뉴스
 
로그인
 
도움말
 
기계 번역
1. (WO2002085859) HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
국제사무국에 기록된 최신 서지정보   

공개번호:    WO/2002/085859    국제출원번호:    PCT/US2002/012064
공개일: 31.10.2002 국제출원일: 17.04.2002
국제예비심사 청구일:    04.10.2002    
IPC:
A61K 31/44 (2006.01), A61K 31/47 (2006.01), A61K 31/4709 (2006.01), A61K 31/4725 (2006.01), C07D 213/75 (2006.01), C07D 215/38 (2006.01), C07D 217/22 (2006.01), C07D 401/12 (2006.01)
출원인: BAYER CORPORATION [US/US]; 100 Bayer Road, Pittsburgh, PS 15205 (US) (For All Designated States Except US).
DUMAS, Jacques [FR/US]; (US) (For US Only).
RIEDL, Bernd [DE/DE]; (DE) (For US Only).
KHIRE, Uday [IN/US]; (US) (For US Only).
SIBLEY, Robert, N. [US/US]; (US) (For US Only).
HATOUM-MOKDAD, Holia [US/US]; (US) (For US Only).
MONAHAN, Mary-Katherine [US/US]; (US) (For US Only).
GUNN, David, E. [US/US]; (US) (For US Only).
LOWINGER, Timothy, B. [CA/JP]; (DE) (For US Only).
SCOTT, William, J. [US/US]; (US) (For US Only).
SMITH, Roger, A. [US/US]; (US) (For US Only).
WOOD, Jill, E. [US/US]; (US) (For US Only)
발명자: DUMAS, Jacques; (US).
RIEDL, Bernd; (DE).
KHIRE, Uday; (US).
SIBLEY, Robert, N.; (US).
HATOUM-MOKDAD, Holia; (US).
MONAHAN, Mary-Katherine; (US).
GUNN, David, E.; (US).
LOWINGER, Timothy, B.; (DE).
SCOTT, William, J.; (US).
SMITH, Roger, A.; (US).
WOOD, Jill, E.; (US)
대리인: ZELANO, Anthony, J.; Millen, White, Zelano & Branigan, P.C., Suite 1400, Arlington Courthouse Plaza I, 2200 Clarendon Boulevard, Arlington, VA 22201 (US)
우선권 정보:
09/838,286 20.04.2001 US
발명의 명칭: (EN) HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
(FR) UREES HETEROARYLES CONTENANT DES HETERO-ATOMES D'AZOTE COMME INHIBITEURS DE KINASE P38
요약서: front page image
(EN)This invention relates to the use of a group of heteroaryl ureas containing nitrogen in treating p38 mediated diseases, and pharmaceutical compositions for use in such therapy.
(FR)L'invention concerne l'utilisation d'un groupe d'urées hétéroaryles contenant de l'azote dans le traitement de maladies causées par p38, ainsi que des compositions pharmaceutiques destinées à une telle thérapie.
지정국: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
공개언어: English (EN)
출원언어: English (EN)